These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3955402)

  • 41. Mexiletine for arrhythmias.
    Med Lett Drugs Ther; 1986 Jul; 28(717):65-6. PubMed ID: 3523180
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of kidney, liver or heart insufficiency on blood mexiletine levels].
    Nitsch J; Steinbeck G; Lüderitz B
    Internist (Berl); 1982 May; 23(5):291-3. PubMed ID: 7047453
    [No Abstract]   [Full Text] [Related]  

  • 43. [Kinetics of mexiletine elimination in 7 healthy volunteers].
    Prat G; Andresen M; Gazitúa R; Serrat H; Corvalán R; Ruiz M; Leiva P
    Rev Med Chil; 1987 Jan; 115(1):40-3. PubMed ID: 3616249
    [No Abstract]   [Full Text] [Related]  

  • 44. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mexiletine in normal volunteers.
    Campbell NP; Kelly JG; Adgey AA; Shanks RG
    Br J Clin Pharmacol; 1978 Oct; 6(4):372-3. PubMed ID: 698033
    [No Abstract]   [Full Text] [Related]  

  • 46. The development of intravenous mexiletine dose regimes.
    Prescott LF
    Postgrad Med J; 1977; 53 Suppl 1():124-7. PubMed ID: 876944
    [No Abstract]   [Full Text] [Related]  

  • 47. Theophylline-mexiletine interaction: a case report.
    Kendall JD; Chrymko MM; Cooper BE
    Pharmacotherapy; 1992; 12(5):416-8. PubMed ID: 1437703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of a dosage scheme for simultaneous intravenous and oral administration of mexiletine.
    Paalman AC; Siebelink J; Roos JC; Dunning AJ
    Postgrad Med J; 1977; 53 Suppl 1():128-33. PubMed ID: 876945
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mexiletine, a drug with anti-arrhythmic action. Experimental research on the cardiovascular system].
    Caputi AP; Rossi F; Lampa E; Imperatore A; Visone C; Marmo E
    Arch Sci Med (Torino); 1979; 136(1):1-15. PubMed ID: 464786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 51. Tocainide and mexiletine. Orally effective lidocaine analogues.
    Roden DM
    Arch Intern Med; 1985 Mar; 145(3):417-8. PubMed ID: 3919665
    [No Abstract]   [Full Text] [Related]  

  • 52. [Kinetics and tolerance of a combined intravenous and oral dose of mexiletine during the sub acute phase of myocardial infarction (author's transl)].
    Leizorovicz A; Pignat E; Mille A; Boissel JP; Ferry S; Guilluy M; Touboul P
    Therapie; 1981; 36(4):413-20. PubMed ID: 7027523
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mexiletine metabolites: a review.
    Catalano A; Carocci A; Sinicropi MS
    Curr Med Chem; 2015; 22(11):1400-13. PubMed ID: 25723511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
    Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
    [No Abstract]   [Full Text] [Related]  

  • 58. [Relative biological availability of quinidine VUFB retard tablets in dogs].
    Sedlmayer P; Sispera L
    Cesk Farm; 1983 Jul; 32(5):164-6. PubMed ID: 6883523
    [No Abstract]   [Full Text] [Related]  

  • 59. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.